M&A Deal Summary

New Zealand Pharmaceuticals Acquires Dextra Laboratories

On September 2, 2009, New Zealand Pharmaceuticals acquired life science company Dextra Laboratories from Summit Therapeutics

Acquisition Highlights
  • This is New Zealand Pharmaceuticals’ 1st transaction in the Life Science sector.
  • This is New Zealand Pharmaceuticals’ 1st transaction in the United Kingdom.

M&A Deal Summary

Date 2009-09-02
Target Dextra Laboratories
Sector Life Science
Buyer(s) New Zealand Pharmaceuticals
Sellers(s) Summit Therapeutics
Deal Type Divestiture

Target

Dextra Laboratories

Reading, United Kingdom
Dextra Laboratories Ltd. is involved in developing innovative solutions to minimise costs, reduce technology transfer issues and optimise robust route generation. The company supplies rare sugars, oligosaccharides and chiral molecules for medical research, diagnostics and pharmaceutical applications.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

New Zealand Pharmaceuticals

Palmerston North, New Zealand

Category Company
Founded 1971
Sector Medical Products
DESCRIPTION

New Zealand Pharmaceuticals Ltd. is a developer and manufacturer of biopharmaceutical products including high purity bile acids, specialized blood group products, complex carbohydrates, and other pharmaceutical intermediates. New Zealand Pharmaceuticals Ltd. was founded in 1971 and is based in Palmerston North, New Zealand.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: United Kingdom M&A 1 of 1
Year: 2009 M&A 1 of 1

Seller(S) 1

SELLER

Summit Therapeutics

Miami, Florida, United States

Category Company
Founded 2003
Sector Life Science
Employees159
Revenue 1M USD (2022)
DESCRIPTION

Summit Therapeutics is a biopharmaceutical company focused on the discovery and development of novel medicines to treat the fatal muscle wasting disease Duchenne muscular dystrophy and infections caused by the bacteria C. difficile. Summit Therapeutics was founded in 2003 and is based in Miami, Florida.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: United Kingdom M&A 1 of 1
Year: 2009 M&A 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-12-23 Discuva

Cambridge, United Kingdom

Discuva Ltd. is a drug discovery company. Discuva was founded in 2007 and is based in Cambridge, United Kingdom.

Buy -